{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-23-009006","form_type":"8-K","ticker":"CNSP","cik":"0001729427","company_name":"CNS Pharmaceuticals, Inc.","filed_at":"2023-12-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.211451+00:00","generated_at":"2026-06-07T09:11:57.484996+00:00","sec_items":["7.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"CNS Pharmaceuticals holds virtual investor update; no specific results disclosed","bullets":["Company held a virtual update meeting on Dec 21, 2023 with CEO John Climcao and CMO Dr. Sandra Silberman.","Meeting link provided in filing but no financial or clinical data included in the 8-K.","Filing under Regulation FD; no material new information furnished in the report."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-23-009006","json":"https://secwatch.observer/filing/0001683168-23-009006.json","markdown":"https://secwatch.observer/filing/0001683168-23-009006.md","text":"https://secwatch.observer/filing/0001683168-23-009006.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1729427/000168316823009006/0001683168-23-009006-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1729427/000168316823009006/cns_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T09:11:57.484996+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}